Update on Adrenarche-Still a Mystery

Area of Science:

• Pediatric endocrinology
• Human development
• Adrenal gland function

Background:

• Adrenarche is a normal developmental stage where the adrenal cortex increases androgen production around age 8-9.
• Premature adrenarche (PA) occurs earlier, but its molecular regulation and long-term health consequences remain largely unknown.
• PA is currently a diagnosis of exclusion, lacking precise diagnostic criteria.

Purpose of the Study:

• To review current knowledge on adrenarche and premature adrenarche.
• To highlight the need for revised definitions and further research into the mechanisms and significance of adrenarche.
• To identify children at risk for adverse health outcomes associated with adrenarche variations.

Main Methods:

• A comprehensive literature search was conducted across major scientific databases (PubMed, ScienceDirect, Web of Science, Embase, Scopus).
• The search focused on studies published within the last 5 years, using keywords related to adrenarche, pubarche, and adrenal steroidogenesis.
• Included were original articles, reviews, and meta-analyses to synthesize existing evidence.

Main Results:

• While studies have advanced understanding of adrenal development and zona reticularis function, the precise triggers for adrenarche remain elusive.
• The 11-oxy androgen pathway, including 11-ketotestosterone, shows promise as a marker for adrenarche.
• Current definitions yield high PA prevalence (up to 23% in girls, 10% in boys), but only a fraction may experience adverse outcomes.

Conclusions:

• New criteria are essential for defining adrenarche and PA to accurately identify children needing intervention and avoid over-diagnosis in normal variations.
• Further research is imperative to elucidate the molecular mechanisms underlying adrenarche.
• Long-term prospective studies are needed to link developmental pathways (prenatal, postnatal growth, obesity) to adrenarche, puberty, and subsequent health outcomes.